KSC (40mg/kg) enhanced markedly the antileukemic and immunopotentiating activities of T AK/L IL 2 therapy. The rate of life prolongation was 36%,and the cure rate of the leukemia mice was doubled.
英
美
- KSC（40mg/kg）對T－AK/L－IL－2的抗白血病作用有明顯的增強效應，荷瘤小鼠細胞免疫功能進(jìn)一步增強，生命延長(cháng)率、長(cháng)期存活率分別提高36%25和99.；9%25。
